Fresh analysis suggests that individuals who come off new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass far faster than those who end traditional lifestyle programs.
Findings released in a leading medical journal shows that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users purchasing such treatments need to be aware of the potential of rapid rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a return to starting mass in about a year and a half.
Analyzing Therapies
The analysis, which reviewed 37 of studies involving thousands of patients, compared the results of these new drugs with other pills.
Researchers point out that people who shed pounds through diet and exercise usually see a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Fast Rebound
Experts believe the mechanism of the jabs is key to understanding the amplified weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication leads to hunger is unsuppressed, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts argue that, given the likelihood of weight regain, the treatment might need to be ongoing.
This view is supported by pharmaceutical companies, who state that the findings "highlight the persistent character of obesity," akin to managing conditions like high blood pressure.
Patient Accounts
People who have come off the jabs describe a sudden return of cravings.
"It was like a trigger that goes on and I was suddenly ravenous," said one woman.
This challenge is exacerbated if individuals have not developed permanent lifestyle or habit modifications during therapy.
Widespread Use
Survey data show that a significant number of adults in the UK have used these injections in the past year, with demand remaining high.
- Adoption is more common among females than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Ultimately, clinicians caution that while the jabs are potent agents for shedding pounds, they are not a magic fix and long-term success hinges on combined lifestyle support.
